Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2016 Dec;8(6):533-540.
doi: 10.5114/jcb.2016.64112. Epub 2016 Dec 2.

Non-melanoma skin cancer treated with high-dose-rate brachytherapy: a review of literature

Durim Delishaj  1 , Agata Rembielak  2 , Bruno Manfredi  1 , Stefano Ursino  1 , Francesco Pasqualetti  1 , Concetta Laliscia  1 , Francesca Orlandi  1 , Riccardo Morganti  3 , Maria Grazia Fabrini  1 , Fabiola Paiar  1
Affiliations
Review

Non-melanoma skin cancer treated with high-dose-rate brachytherapy: a review of literature

Durim Delishaj et al. J Contemp Brachytherapy. 2016 Dec.

Abstract

Purpose: The incidence of non-melanoma skin cancer (NMSC) has been increasing over the past 30 years. There are different treatment options and surgical excision is the most frequent treatment due to its low rates of recurrence. Radiotherapy is an effective alternative of surgery, and brachytherapy (BT) might be a better therapeutic option due to high radiation dose concentration to the tumor with rapid dose fall-off resulting in normal tissues sparing. The aim of this review was to evaluate the local control, toxicity, and cosmetic outcomes in NMSC treated with high-dose-rate BT (HDR-BT).

Material and methods: In May 2016, a systematic search of bibliographic database of PubMed, Web of Science, Scopus, and Cochrane Library with a combination of key words of "skin cancer", "high dose rate brachytherapy", "squamous cell carcinoma", "basal cell carcinoma", and "non melanoma skin cancer" was performed. In this systematic review, we included randomized trials, non-randomized trials, prospective and retrospective studies in patients affected by NMSC treated with HDR-BT.

Results: Our searches generated a total of 85 results, and through a process of screening, 10 publications were selected for the review. Brachytherapy was well tolerated with acceptable toxicity and high local control rates (median: 97%). Cosmetic outcome was reported in seven study and consisted in an excellent and good cosmetic results in 94.8% of cases.

Conclusions: Based on the review data, we can conclude that the treatment of NMSC with HDR-BT is effective with excellent and good cosmetics results, even in elderly patients. The hypofractionated course appears effective with very good local disease control. More data with large-scale randomized controlled trials are needed to assess the efficacy and safety of brachytherapy.

Keywords: HDR brachytherapy; radiotherapy; skin brachytherapy; skin cancer.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Flow chart of systematic literature search process
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Lomas A, Leonardi-Bee J, Bath-Hextall F. A systematic review of worldwide incidence of nonmelanoma skin cancer. Br J Dermatol. 2012;166:1069–1080. - PubMed
    1. Eisemann N, Waldmann A, Geller AC, et al. Non-melanoma skin cancer incidence and impact of skin cancer screening on incidence. J Invest Dermatol. 2014;134:43–50. - PubMed
    1. Kricker A, Armstrong BK, English DR, et al. Does intermittent sun exposure cause basal cell carcinoma. A case-control study in Western Australia. Int J Cancer. 1995;60:489–494. - PubMed
    1. Zanetti R, Rosso S, Martinez C, et al. The multicentre south European study ‘Helios’. I: Skin characteristics and sunburns in basal cell and squamous cell carcinomas of the skin. Bitr J Cancer. 1996;73:1440–1446. - PMC - PubMed
    1. Katalinic A, Kunze U, Schäfer T. Epidemiology of cutaneous melanoma and non-melanoma skin cancer in Schleswig-Holstein, Germany: incidence, clinical subtypes, tumour stages and localization (epidemiology of skin cancer) Br J Dermatol. 2003;149:1200–1206. - PubMed